Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.


TSXV:XRTX - Post by User

Comment by KOkidneydiseaseon Nov 19, 2021 6:05pm
84 Views
Post# 34148264

RE:RE:RE:RE:RE:RE:RE:Significantly Undervalued and Strong Buy

RE:RE:RE:RE:RE:RE:RE:Significantly Undervalued and Strong BuyHi Space

1.What I said was 'when funds get RRSP and TFSA money in Feb they generaly look to place that money at that time'. Now if these particular funds invest in our company I don't know, Id have to do some research but off the cuff I'm sure there are some funds that have RRSP funds allocated within. BTW - I won't be doing the research because the point is preyyu common sense.

2,3,4 - If we didn't do the roll back we are not getting on the Nasdaq and we aren't getting $14mm US$ and we aren't moving forward so our Company dies and we all lose our investment. as for the price? If we had a truck load of the best steaks on earth and we wanted $1,000 for each steak but the market said the steaks are only worth $100 each, you either go with what the market will bare or you let the steaks rot waiting for your $1,000. XORTX took what the market will bare and now they go on with that $$, put it to use to increase the value of XORTX and the share price increases. Pretty simple.

out of curiousity Space, what would you have done? did you have anyone lined up to pay us a higher $$ for the financing?

Thanks
<< Previous
Bullboard Posts
Next >>